0001250853-22-000063.txt : 20220519
0001250853-22-000063.hdr.sgml : 20220519
20220519205132
ACCESSION NUMBER: 0001250853-22-000063
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200607
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verleun Noah
CENTRAL INDEX KEY: 0001862713
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12627
FILM NUMBER: 22945033
MAIL ADDRESS:
STREET 1: 2709 SKYPARK DRIVE
STREET 2: SUITE 105
CITY: TORRANCE
STATE: CA
ZIP: 90505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Clean Energy Holdings, Inc.
CENTRAL INDEX KEY: 0000748790
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 870407858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2790 SKYPARK DRIVE, SUITE 105
CITY: TORRANCE
STATE: CA
ZIP: 90505
BUSINESS PHONE: (310) 641-4234
MAIL ADDRESS:
STREET 1: 2790 SKYPARK DRIVE, SUITE 105
CITY: TORRANCE
STATE: CA
ZIP: 90505
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICAL DISCOVERIES INC
DATE OF NAME CHANGE: 19940303
FORMER COMPANY:
FORMER CONFORMED NAME: WPI PHARMACEUTICAL INC
DATE OF NAME CHANGE: 19930126
FORMER COMPANY:
FORMER CONFORMED NAME: WESTPORT PHARMACEUTICAL INC
DATE OF NAME CHANGE: 19850111
3/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3/A
2020-06-07
2021-06-22
0
0000748790
Global Clean Energy Holdings, Inc.
GCEH
0001862713
Verleun Noah
2790 SKYPARK DRIVE
SUITE 105
TORRANCE
CA
90505
0
1
0
0
EVP - Development & Regulatory
Stock Option (right to buy)
0.0035
2023-09-16
Common Stock
2757143
D
The stock option was 25% vested on the grant date (09/17/2018). The remaining 75% vested in 36 equal installments beginning on the grant date.
The original Form 3 underreported the number of shares by 500,000 shares. The original Form 3 reported 2,257,143 shares; it should have reported 2,757,143 shares.
The Issuer effected a 1-for-10 reverse stock split on March 26, 2021, which subsequently reduced the number of options to 275,714 and increased the conversion price to $0.035.
On the date that the original Form 3 was filed, 06/22/2021, the title of the reporting person was EVP - Development & Regulatory Affairs.
On the date that this amendment is being filed, 05/19/2022, the title of the reporting person is President.
/s/ Noah Verleun
2022-05-19